Lower 123I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies

Lower 123I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies

In this retrospective cross-sectional study we compared 123I‑N‑ω‑fluoropropyl‑2β‑carbomethoxy‑3β‑(4‑iodophenyl)nortropane (123I-FP-CIT) binding to the striatal dopamine and the extrastriatal serotonin transporter (DAT and SERT, respectively) between Parkinson's disease (PD) and dementia with Le...

Full description

Bibliographic Details
Main Authors:	Merijn Joling, Chris Vriend, Jessica J. van der Zande, Afina W. Lemstra, Odile A. van den Heuvel, Jan Booij, Henk W. Berendse
Format:	Article
Language:	English
Published:	Elsevier 2018-01-01
Series:	NeuroImage: Clinical
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213158218301189

Similar Items

Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An 123I-FP-CIT SPECT study
by: Merijn Joling, et al.
Published: (2019-01-01)

Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An 123I-FP-CIT SPECT study
by: J.J. van der Zande, et al.
Published: (2020-01-01)

Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
by: Nicolas Nicastro, et al.
Published: (2020-05-01)

Processing speed is related to striatal dopamine transporter availability in Parkinson's disease
by: Chris Vriend, et al.
Published: (2020-01-01)

Intranasal dopamine reduces in vivo [123I]FP-CIT binding to striatal dopamine transporter: correlation with behavioral changes and evidence for Pavlovian conditioned dopamine response
by: Maria A de Souza Silva, et al.
Published: (2016-04-01)

In vivo absolute quantification of striatal and extrastriatal D2/3 receptors with [123I]epidepride SPECT
by: Stergios Tsartsalis, et al.
Published: (2020-06-01)

[123I]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor.
by: Katzenschlager, R, et al.
Published: (2003)

Imaging of dopamine transporters in Parkinson disease: a meta‐analysis of 18F/123I‐FP‐CIT studies
by: Yanyan Kong, et al.
Published: (2020-09-01)

Comparison of [18F]-FDOPA PET and [123I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome
by: Elon Wallert, et al.
Published: (2022-10-01)

Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat
by: H.H. Ruocco, et al.
Published: (2006-08-01)

[18F]fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson's disease
by: Adam J. Stark, et al.
Published: (2018-01-01)

Longitudinal evaluation using FP-CIT in patients with parkinsonism
by: M.D. Martínez-Valle Torres, et al.
Published: (2014-07-01)

Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT—a clinical comparison
by: Susanna Jakobson Mo, et al.
Published: (2018-11-01)

Bipolar Disorder and Parkinson disease: a 123I-FP-CIT SPECT study
by: G. D’agostino, et al.
Published: (2023-03-01)

Computer-aided diagnosis for (123I)FP-CIT imaging: impact on clinical reporting
by: Jonathan Christopher Taylor, et al.
Published: (2018-05-01)

Reduced D2/D3 Receptor Binding of Extrastriatal and Striatal Regions in Temporal Lobe Epilepsy.
by: Viviane E Bernedo Paredes, et al.
Published: (2015-01-01)

Random forest to differentiate dementia with Lewy bodies from Alzheimer's disease
by: Meenakshi Dauwan, et al.
Published: (2016-01-01)

EEG Characteristics of Dementia With Lewy Bodies, Alzheimer’s Disease and Mixed Pathology
by: Jessica J. van der Zande, et al.
Published: (2018-07-01)

Evaluación longitudinal con FP-CIT en pacientes con parkinsonismo
by: M.D. Martínez-Valle Torres, et al.
Published: (2014-07-01)

A Novel Automatic Approach for Calculation of the Specific Binding Ratio in [I-123]FP-CIT SPECT
by: Mahmudur G. M. Rahman, et al.
Published: (2020-05-01)

[18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
by: Lisbeth Marner, et al.
Published: (2022-09-01)

Clinical evaluation of [123I]FP-CIT SPECT scans on the novel brain-dedicated InSPira HD SPECT system: a head-to-head comparison
by: Sofie M. Adriaanse, et al.
Published: (2018-08-01)

Putamen–midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases
by: A. Rieckmann, et al.
Published: (2015-01-01)

Extrastriatal dopaminergic circuits of the basal ganglia
by: Karen Suzanne Rommelfanger, et al.
Published: (2010-10-01)

Occupational exposure to PCBs reduces striatal dopamine transporter densities only in women: A β-CIT imaging study
by: Richard F. Seegal, et al.
Published: (2010-05-01)

Serial changes of I-123 FP-CIT SPECT binding asymmetry in Parkinson's disease: Analysis of the PPMI data
by: Eun Hye Jeong, et al.
Published: (2022-09-01)

123I-FP-CIT SPECT imaging in early diagnosis of dementia in patients with and without a vascular component
by: Marina eGarriga, et al.
Published: (2015-07-01)

Correction: [18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
by: Lisbeth Marner, et al.
Published: (2023-03-01)

Radioiodination and Purification of [<sup>131</sup>I]β-CIT and [<sup>131</sup>I]FP-CIT with an Automated Radiosynthesizer
by: Elisabeth Plhak, et al.
Published: (2022-01-01)

Association between striatal subregions and extrastriatal regions in dopamine D(1) receptor expression: a positron emission tomography study.
by: Hironobu Fujiwara, et al.
Published: (2012-01-01)

123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders: First results
by: Jauković Ljiljana, et al.
Published: (2012-01-01)

Comparison of machine learning and semi-quantification algorithms for (I123)FP-CIT classification: the beginning of the end for semi-quantification?
by: Jonathan Christopher Taylor, et al.
Published: (2017-11-01)

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
by: Inger van Steenoven, et al.
Published: (2019-10-01)

Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson’s Disease: A Multicenter Study
by: Maria Silvia De Feo, et al.
Published: (2023-08-01)

Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [123I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson’s disease
by: Sven R. Suwijn, et al.
Published: (2019-07-01)

Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndrome
by: Minyoung Oh, et al.
Published: (2023-09-01)

Dynamic multi-pinhole collimated brain SPECT of Parkinson’s disease by [123I]FP-CIT: a feasibility study of fSPECT
by: Filip L. H. Fredensborg, et al.
Published: (2024-03-01)

Automated synthesis of dopamine transporters imaging probe 18F-FP-CIT based on allin one for Micro PET/CT imaging of rat basal ganglia
by: QU Qian, HAI Wangxi, HU Shengyan, ZHANG Min, CHEN Xiaoyue, ZHOU Yilei, WANG Jin, HU Xiaoping, LI Biao, HU Jiajia
Published: (2022-08-01)

Effect of cerebrospinal fluid area mask correction on 123I-FP-CIT SPECT images in idiopathic normal pressure hydrocephalus
by: Makoto Ohba, et al.
Published: (2023-06-01)

Combination of compressed sensing-based iterative reconstruction and offset acquisition for I-123 FP-CIT SPECT: a simulation study
by: Norikazu Matsutomo, et al.
Published: (2022-06-01)